Volume 10, Number 12—December 2004
Dispatch
Animal-to-Human Transmission of Salmonella Typhimurium DT104A Variant
Susan W.M. Hendriksen*
, Karin Orsel*, Jaap A. Wagenaar*, Angelika Miko†, and Engeline van Duijkeren*
, Karin Orsel*, Jaap A. Wagenaar*, Angelika Miko†, and Engeline van Duijkeren*
Table
Three Salmonella enterica serovar Typhimurium DT 104A isolates from a boy, a pig, and a calf on a Dutch farm, with MIC values for antimicrobial drugs
| Antimicrobial drug | MIC (μg/mL)a |
||
|---|---|---|---|
| Porcine strain | Bovine strain | Human strain | |
| Tetracycline | >32 R | >32 R | >32 R |
| Sulfamethoxazole | >512 R | >512 R | >512 R |
| Spectinomycin | 32 S | 32 S | 32 S |
| Chloramphenicol | 8 S | 8 S | 8 S |
| Florfenicol | 8 S | 8 S | 8 S |
| Streptomycin | 8 S | 32 R | 16 I |
| Ampicillin | 2 S | 2 S | 2 S |
| Neomycin | <2 S | <2 S | <2 S |
| Amoxycillin-clavulanic acid | <2/1 S | <2/1 S | <2/1 S |
| Nalidixic acid | <4 S | 8 S | <4 S |
| Gentamicin | <1 S | <1 S | <1 S |
| Trimethoprim | >32 R | >32 R | >32 R |
| Colistin sulfate | <4 S | <4 S | <4 S |
| Trimethoprim-sulfamethoxazole | >8/152 R | >8/152 R | >8/152 R |
| Ciprofloxacin | <0.03 S | <0.03 S | <0.03 S |
| Ceftiofur | 1 S | 1 S | 1 S |
| Kanamycin | <4 S | 8 S | <4 S |
aThe categories susceptible (S), intermediate (I), or resistant (R) were assigned on the basis of breakpoints recommended by the National Committee for Clinical Laboratory Standards and the Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (11,12).
Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.